Cost Effectiveness of Different Targeted Treatment Sequences for HER2-Positive Metastatic Breast Cancer
May 1, 2016, 00:00
10.1016/j.jval.2016.03.1592
https://www.valueinhealthjournal.com/article/S1098-3015(16)01660-0/fulltext
Title :
Cost Effectiveness of Different Targeted Treatment Sequences for HER2-Positive Metastatic Breast Cancer
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01660-0&doi=10.1016/j.jval.2016.03.1592
First page :
A150
Section Title :
Cancer - Cost Studies
Open access? :
No
Section Order :
314